ClinicalTrials.gg
Sign In

HIV Seropositivity clinical trials

The registry lists 194 studies for HIV Seropositivity across more than 10 countries. 11 are recruiting or about to start. 105 of them are mainly about HIV Seropositivity (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the HIV Seropositivity studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
146
Status unknown
19
Terminated
10
Recruiting
6
Active, not recruiting
5
Not yet recruiting
4

Phase

Phase 2
25
Phase 4
14
Phase 1
13
Phase 3
13
Early Phase 1
2

Where

United States
83
France
22
South Africa
9
Zambia
6
Brazil
4
Uganda
4

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (16) · University of Washington (6) · ANRS, Emerging Infectious Diseases (5) · University of North Carolina, Chapel Hill (5) · University Hospital, Ghent (3) · National Cancer Institute (NCI) (3) · University of California, San Diego (3) · Wayne State University (3)

What is being tested here

Drugs under test in HIV Seropositivity studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Mivocabtagene autoleucel101
Raltegravir024
Lamivudine033
Zidovudine003
poly(I).poly(c12,U)003
Tenofovir012
Chondrus crispus carrageenan012
Efavirenz002
Thymopentin002
Human Papillomavirus Recombinant Vaccine nonavalent001

Drug classes tested here Reverse transcriptase inhibitors 12 · Integrase inhibitors 6 · Statins 3

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 6 HIV Seropositivity studies recruiting now, 2 (33%) set no upper age limit and 2 (33%) stop at 75 or younger. 1 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (83%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
100 (0%)0 (0%)
186 (100%)6 (100%)
306 (100%)6 (100%)
406 (100%)6 (100%)
505 (83%)5 (83%)
655 (83%)5 (83%)
754 (67%)4 (67%)
853 (50%)3 (50%)

Across all 194 studies, recruiting or not: 33% stop at 75 or younger and 29% at 65; 21% take children; 9% are for women only and 9% for men only; 35% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long HIV Seropositivity studies take

Of 29 interventional studies with no phase under HIV Seropositivity, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase23 mo8–46 · 29 studies—23 mo8–46 · 28 studies
Observational43 mo19–130 · 24 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 194. Browse all 194 → or search them.